{"id":784504,"date":"2023-09-18T08:55:42","date_gmt":"2023-09-18T12:55:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/"},"modified":"2023-09-18T08:55:42","modified_gmt":"2023-09-18T12:55:42","slug":"ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/","title":{"rendered":"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Morgan Stanley Fireside Chat Replay Now Available<\/li>\n<\/ul>\n<p>SAN DIEGO, Sept.  18, 2023  (GLOBE NEWSWIRE) &#8212; Ambrx Biopharma Inc., Ambrx (or the \u201cCompany\u201d) (NASDAQ: AMAM), today announced that Daniel J. O\u2019Connor, Chief Executive Officer and President of Ambrx, will participate in a fireside chat and one-on-one meetings at the Cantor Fitzgerald Global Healthcare conference, being held in New York, NY.<\/p>\n<p>Presentation details are below:<\/p>\n<p>\n        <strong>Cantor Fitzgerald Global Healthcare Conference: <\/strong><br \/>\n        <br \/>Date: Wednesday, September 27, 2023<br \/>Time: 10:20 AM ET<\/p>\n<p>A replay of Daniel J. O\u2019Connor\u2019s Fireside Chat at the Morgan Stanley Annual Global Healthcare Conference is now available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ga8uceFUqTr9srUW5Q7QgELWgvaOo9J2F9urWpJrDFgJnBJovKQe-6uPyT4sjGFlgalO4d9rg67IKnIFkPdJlSlWPAzT6TezYSv38fNrl4fS-w48CQXO5cz9GkpvSe6yk8gBVxjvOszfNQBc5cbI5NLchIGfxDr9EWCWlXtJcP3r7B89NzwYP9O1etzt7cSi\" rel=\"nofollow noopener\" target=\"_blank\">Events and Presentations section of the Ambrx website<\/a>.\u00a0\u00a0<\/p>\n<p>\n        <strong>About Ambrx Biopharma Inc.<\/strong>\n      <\/p>\n<p>Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. Ambrx is advancing a focused portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. In addition, Ambrx has preclinical and clinical collaborations with multiple partners on drug candidates generated using Ambrx technology. Ambrx spun out of The Scripps Research Institute in 2003 and has several other product candidates involving ADCs and other aspects of Ambrx\u2019s protein engineering technology. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=umi9IEjkCo9IDiBrqcmQBNetj0dZQrcmGpUJWPBPUaTcmS89Afy5HSdgsOjw8ju5WIvXibwi_MijSTDZ_EJ0kw==\" rel=\"nofollow noopener\" target=\"_blank\">www.ambrx.com<\/a>. Ambrx routinely posts information that may be important to investors on its website.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release includes certain \u201cforward-looking statements\u201d intended to qualify for the \u201csafe harbor\u201d from liability established by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements may be identified by the words \u201cintend,\u201d \u201cplan,\u201d and similar expressions. Forward-looking statements are based on Ambrx\u2019s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, those risks and uncertainties associated with: the continuing impact of the COVID-19 pandemic and other public health-related risks and events on Ambrx\u2019s business, operations, strategy, goals and anticipated milestones; Ambrx\u2019s ability to execute on its strategy including with respect to the timing of its R&amp;D efforts, initiation of clinical trials and other anticipated milestones; risks associated with development and marketing approval of novel therapeutics, including potential delays in clinical trials and regulatory submissions and the fact that future clinical trial results\/data may not be consistent with interim, initial or preliminary results\/data or results\/data from prior preclinical studies or clinical trials; Ambrx\u2019s ability to fund operations as anticipated; and the additional risks and uncertainties set forth more fully under the caption \u201cRisk Factors\u201d in Ambrx\u2019s Quarterly Report on Form 10-Q filed with the SEC on August 9, 2023, and elsewhere in Ambrx\u2019s filings and reports with the SEC, including the prospectus supplement to be filed in connection with the Offering. Forward-looking statements contained in this press release are made as of this date, and Ambrx undertakes no duty to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.<\/p>\n<p>Contacts<\/p>\n<p>INVESTORS<br \/>Mike Moyer<br \/>LifeSci Advisors<br \/>617-308-4306<br \/>mmoyer@lifesciadvisors.com<\/p>\n<p>MEDIA<br \/>Hannah Holmquist<br \/>LifeSci Communications<br \/>619-723-4326<br \/>media@ambrx.com<\/p>\n<p>Source: Ambrx Biopharma, Inc.<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTA3MzRjYWYtOTY2MS00NTAzLTk4MmQtODYzMDJmOTAyOTc0LTEyNjM3NjU=\/tiny\/Ambrx-Biopharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Morgan Stanley Fireside Chat Replay Now Available SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) &#8212; Ambrx Biopharma Inc., Ambrx (or the \u201cCompany\u201d) (NASDAQ: AMAM), today announced that Daniel J. O\u2019Connor, Chief Executive Officer and President of Ambrx, will participate in a fireside chat and one-on-one meetings at the Cantor Fitzgerald Global Healthcare conference, being held in New York, NY. Presentation details are below: Cantor Fitzgerald Global Healthcare Conference: Date: Wednesday, September 27, 2023Time: 10:20 AM ET A replay of Daniel J. O\u2019Connor\u2019s Fireside Chat at the Morgan Stanley Annual Global Healthcare Conference is now available on the Events and Presentations section of the Ambrx website.\u00a0\u00a0 About Ambrx Biopharma Inc. Ambrx is a clinical stage biopharmaceutical company using an expanded genetic &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-784504","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Morgan Stanley Fireside Chat Replay Now Available SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) &#8212; Ambrx Biopharma Inc., Ambrx (or the \u201cCompany\u201d) (NASDAQ: AMAM), today announced that Daniel J. O\u2019Connor, Chief Executive Officer and President of Ambrx, will participate in a fireside chat and one-on-one meetings at the Cantor Fitzgerald Global Healthcare conference, being held in New York, NY. Presentation details are below: Cantor Fitzgerald Global Healthcare Conference: Date: Wednesday, September 27, 2023Time: 10:20 AM ET A replay of Daniel J. O\u2019Connor\u2019s Fireside Chat at the Morgan Stanley Annual Global Healthcare Conference is now available on the Events and Presentations section of the Ambrx website.\u00a0\u00a0 About Ambrx Biopharma Inc. Ambrx is a clinical stage biopharmaceutical company using an expanded genetic &hellip; Continue reading &quot;Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-18T12:55:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference\",\"datePublished\":\"2023-09-18T12:55:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/\"},\"wordCount\":569,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/\",\"name\":\"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=\",\"datePublished\":\"2023-09-18T12:55:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk","og_description":"Morgan Stanley Fireside Chat Replay Now Available SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) &#8212; Ambrx Biopharma Inc., Ambrx (or the \u201cCompany\u201d) (NASDAQ: AMAM), today announced that Daniel J. O\u2019Connor, Chief Executive Officer and President of Ambrx, will participate in a fireside chat and one-on-one meetings at the Cantor Fitzgerald Global Healthcare conference, being held in New York, NY. Presentation details are below: Cantor Fitzgerald Global Healthcare Conference: Date: Wednesday, September 27, 2023Time: 10:20 AM ET A replay of Daniel J. O\u2019Connor\u2019s Fireside Chat at the Morgan Stanley Annual Global Healthcare Conference is now available on the Events and Presentations section of the Ambrx website.\u00a0\u00a0 About Ambrx Biopharma Inc. Ambrx is a clinical stage biopharmaceutical company using an expanded genetic &hellip; Continue reading \"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-18T12:55:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference","datePublished":"2023-09-18T12:55:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/"},"wordCount":569,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/","name":"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=","datePublished":"2023-09-18T12:55:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMzY1NyM1ODE4NjEwIzIyNTIyMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-participate-in-the-cantor-fitzgerald-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=784504"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784504\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=784504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=784504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=784504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}